Validation & Orientation: Understanding Post-Infectious Neuralgia
At a Glance
Post-infectious neuralgia is real nerve pain that can continue after an infection is no longer active because injured nerves remain overactive and sensitive. Postherpetic neuralgia after shingles is the best-known form, and evaluation can guide symptom management.
It is a strange and deeply frustrating experience to be told by a doctor that an infection is “cleared,” yet you are still in significant pain. You may feel as though your body is stuck in a loop, or that the medical team is missing a lingering spark because the fire is supposedly out.
This experience is often referred to as post-infectious neuralgia. This is an umbrella term for chronic neuropathic pain (pain caused by a lesion or disease of the sensory nervous system) that persists long after the initial virus or bacteria is no longer active [1][2]. While the infection itself has moved on, it has left behind a changed nervous system that continues to send distress signals to your brain.
The Most Common Form: Postherpetic Neuralgia (PHN)
The most widely studied and recognized version of this condition is Postherpetic Neuralgia (PHN). This occurs after a shingles (herpes zoster) infection. While most people recover from shingles without long-term issues, PHN is common:
- Depending on the population and definition used, approximately 10% to 20% of all people who get shingles will develop PHN [3][4].
- The risk increases significantly with age and the severity of the initial pain or rash.
- Medical research typically defines PHN as pain that lasts for at least 90 days after the shingles rash first appeared [5][3], though you do not need to wait 90 days to seek evaluation and symptom management.
Other infections can also be associated with pain. For example, active Lyme disease can lead to radiculoneuritis (Bannwarth syndrome). While post-treatment Lyme disease syndrome is a distinct and debated clinical construct, some patients experience ongoing symptoms [6][7]. More recently, researchers have observed neuralgia (nerve pain) following COVID-19, with estimates varying widely as causality remains under study [8][9].
Why the Pain Outlasts the Infection
The core of the problem in established PHN is that the nerves were injured during the acute phase of the illness. Research has reached a strong consensus on several ways this happens:
- Nerve Damage and Inflammation: During the infection, the virus (like shingles) replicates in the sensory ganglia (the “hubs” where nerve cells live). This causes intense inflammation and can damage nerve cells [10][11].
- Hyperexcitability: Damaged nerves can become overactive. They may develop ion-channel dysregulation, meaning the chemical gates that control electrical signals in your nerves get stuck in the “on” position [11][12].
- Peripheral and Central Sensitization: Your nerves can become so sensitive that they fire spontaneously [13]. Over time, your brain and spinal cord may also become more sensitive to these signals, a proposed mechanism that amplifies the pain [13][14].
What Science Is Still Figuring Out
While we understand that nerves are damaged in PHN, researchers are still looking for answers to several “whys”:
- Predictability: We know that older age and severe initial pain increase the risk of PHN, but we cannot yet predict exactly who will develop it [15][5].
- The Role of the Immune System: Scientists are investigating how neuroimmune signaling might keep the pain going, looking at cytokines [12][16].
- Long-Term Resolution: It remains unclear why the pain eventually fades for some people while remaining a chronic issue for others [17][8].
The Emotional Landscape
Living with post-infectious neuralgia is not just a physical challenge; it is an emotional one. Research confirms that this condition often leads to:
- Sleep Disruption: The burning or “electric” sensations often peak at night, leading to chronic exhaustion [17][18].
- Anxiety and Depression: Studies show that people with chronic nerve pain have higher rates of anxiety and depression [19][20].
- Quality of Life: The pain can interfere with basic activities like wearing clothing or going for a walk, leading to social withdrawal [18][17].
Validating these feelings is a crucial part of care. Acknowledging that the pain is a real biological consequence of nerve injury—rather than assuming it requires more antibiotics, unless a new rash or fever appears—is the first step toward a management plan [21][17].
Common questions in this guide
What is post-infectious neuralgia?
Does ongoing pain mean the infection is still present?
When does pain after shingles become postherpetic neuralgia?
Who is more likely to develop postherpetic neuralgia?
What does post-infectious nerve pain feel like?
How can post-infectious neuralgia affect emotional health?
What treatments might a clinician discuss for post-infectious neuralgia?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my history, do I meet the clinical definition for postherpetic neuralgia or another post-infectious neuralgia?
- 2.What specific evidence from my physical exam suggests my pain is 'neuropathic' rather than related to lingering infection?
- 3.What is the goal for my treatment—complete pain relief, or a certain percentage of improvement in my sleep and daily functioning?
- 4.Which of my symptoms (burning, hypersensitivity, etc.) are most likely to respond to topical treatments like lidocaine versus oral medications?
- 5.Since my infection has passed, what are the proposed mechanisms for why my nerves are still firing pain signals?
- 6.Are there specialists, like a pain management neurologist, you recommend for cases that don't respond to first-line treatments?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
Therapeutic Approaches for Peripheral and Central Neuropathic Pain.
Szok D, Tajti J, Nyári A, Vécsei L
Behavioural neurology 2019; (2019()):8685954 doi:10.1155/2019/8685954.
PMID: 31871494 - 2
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.
Scholz J, Finnerup NB, Attal N, et al.
Pain 2019; (160(1)):53-59 doi:10.1097/j.pain.0000000000001365.
PMID: 30586071 - 3
[Pain Treatment for Herpes zoster].
Gaik C, Volberg C
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 2025; (60(6)):371-375 doi:10.1055/a-2281-1256.
PMID: 40513584 - 4
Herpes Zoster and Postherpetic Neuralgia: Prevention and Management.
Saguil A, Kane S, Mercado M, Lauters R
American family physician 2017; (96(10)):656-663.
PMID: 29431387 - 5
Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.
Forbes HJ, Bhaskaran K, Thomas SL, et al.
Neurology 2016; (87(1)):94-102 doi:10.1212/WNL.0000000000002808.
PMID: 27287218 - 6
Lyme neuroborreliosis: known knowns, known unknowns.
Halperin JJ, Eikeland R, Branda JA, Dersch R
Brain : a journal of neurology 2022; (145(8)):2635-2647 doi:10.1093/brain/awac206.
PMID: 35848861 - 7
Posttreatment Lyme disease syndrome.
Aucott JN
Infectious disease clinics of North America 2015; (29(2)):309-23.
PMID: 25999226 - 8
Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis.
Hoshijima H, Mihara T, Seki H, et al.
PloS one 2023; (18(11)):e0250909 doi:10.1371/journal.pone.0250909.
PMID: 38019841 - 9
COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis.
Williams LD, Zis P
Journal of clinical medicine 2023; (12(4)) doi:10.3390/jcm12041672.
PMID: 36836207 - 10
Varicella zoster virus infection.
Gershon AA, Breuer J, Cohen JI, et al.
Nature reviews. Disease primers 2015; (1()):15016 doi:10.1038/nrdp.2015.16.
PMID: 27188665 - 11
Low-Level Light Therapy in Postherpetic Neuralgia: A Review of Mechanistic Insights and Clinical Implications.
Ma YC, Chiang YC, Yu S
Cellular and molecular neurobiology 2026; (46(1)).
PMID: 42250031 - 12
The Role of Cytokines in Postherpetic Neuralgia.
Shen Y, Lin P
Journal of integrative neuroscience 2025; (24(4)):25829 doi:10.31083/JIN25829.
PMID: 40302252 - 13
Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis.
Devor M
Pain reports 2018; (3(6)):e702 doi:10.1097/PR9.0000000000000702.
PMID: 30706041 - 14
Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study.
Cao S, Li Y, Deng W, et al.
Pain physician 2017; (20(5)):E687-E699.
PMID: 28727713 - 15
A systematic review and meta-analysis of risk factors for postherpetic neuralgia.
Forbes HJ, Thomas SL, Smeeth L, et al.
Pain 2016; (157(1)):30-54 doi:10.1097/j.pain.0000000000000307.
PMID: 26218719 - 16
Immunoinflammatory mechanisms and emerging therapies for postherpetic neuralgia.
He S, Deng D, Luo WF
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(9)).
PMID: 42658336 - 17
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.
Mallick-Searle T, Snodgrass B, Brant JM
Journal of multidisciplinary healthcare 2016; (9()):447-454 doi:10.2147/JMDH.S106340.
PMID: 27703368 - 18
Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial.
Liu Q, Wu X, Guo J, et al.
Pain and therapy 2021; (10(2)):1755-1771 doi:10.1007/s40122-021-00283-8.
PMID: 34254233 - 19
Deficits in ascending and descending pain modulation pathways in patients with postherpetic neuralgia.
Li H, Li X, Feng Y, et al.
NeuroImage 2020; (221()):117186 doi:10.1016/j.neuroimage.2020.117186.
PMID: 32711060 - 20
Sensory symptom profiles differ between trigeminal and thoracolumbar postherpetic neuralgia.
Rehm S, Groβkopf M, Kabelitz M, et al.
Pain reports 2018; (3(1)):e636 doi:10.1097/PR9.0000000000000636.
PMID: 29430564 - 21
8. Herpes zoster and post herpetic neuralgia.
Adriaansen EJM, Jacobs JG, Vernooij LM, et al.
Pain practice : the official journal of World Institute of Pain 2024; doi:10.1111/papr.13423.
PMID: 39364882
This page is for informational purposes only and does not constitute medical advice. A clinician should evaluate persistent pain and any new weakness, numbness, balance changes, rash, or fever.
Get notified when new evidence is published on post-infectious neuralgia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.